Cars.com
CARS
Teradata Corp
TDC
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
Workday
WDAY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 28.19%252.92M | -26.26%67.17M | 560.61%84.02M | 25.84%48.25M | -3.04%53.47M | -27.63%197.3M | 19.94%91.08M | -82.01%12.72M | -32.41%38.34M | -20.38%55.15M |
Net income from continuing operations | 9.86%227.24M | 54.90%65.17M | 12.31%59.91M | -2.49%52.14M | -13.71%50.03M | -17.75%206.85M | -37.87%42.07M | -16.70%53.34M | -13.95%53.47M | 0.62%57.97M |
Operating gains losses | -78.66%-4.92M | -90.67%-1.51M | -64.08%-1.35M | -98.28%-1.38M | -53.39%-678K | -173.86%-2.76M | -54.28%-793K | -5.10%-824K | -131.37%-696K | -115.74%-442K |
Depreciation and amortization | 7.87%4.79M | -8.79%1.09M | 32.48%1.46M | 6.44%1.14M | 2.61%1.1M | 7.59%4.44M | 26.46%1.2M | 3.97%1.1M | 2.98%1.07M | -0.93%1.07M |
Deferred tax | -233.43%-3.35M | -135.75%-1.64M | 60.78%-2.31M | -871.86%-2.03M | 5,259.18%2.63M | 61.57%-1.01M | 248.04%4.58M | -11,432.69%-5.89M | -95.37%263K | 100.93%49K |
Other non cashItems | 274.54%850K | -62.30%792K | 383.67%4.1M | -35.53%-2.16M | -521.92%-1.89M | -130.42%-487K | 201.43%2.1M | -163.66%-1.45M | 39.64%-1.59M | -64.75%447K |
Change in working capital | 80.19%-9.2M | -127.03%-8.76M | 130.92%12.78M | 69.93%-7.55M | 54.29%-5.68M | -13.18%-46.46M | 2,924.93%32.4M | -165.56%-41.34M | 2.06%-25.1M | -1,063.18%-12.43M |
-Change in receivables | 66.42%-3.61M | 54.64%-1.22M | 121.50%1.36M | -582.33%-1.53M | -7.12%-2.23M | 20.84%-10.76M | 68.37%-2.68M | -86.40%-6.32M | 114.62%317K | -569.07%-2.08M |
-Change in payables and accrued expense | -94.61%481K | -49.51%1.45M | -20.59%1.29M | -160.67%-1.53M | -137.54%-723K | 78.74%8.93M | -23.35%2.86M | 18.74%1.62M | 476.12%2.52M | 240.28%1.93M |
-Change in other working capital | 86.40%-6.07M | -127.89%-8.99M | 127.66%10.13M | 83.93%-4.49M | 77.75%-2.73M | -37.52%-44.63M | 796.27%32.22M | -170.56%-36.64M | -22.59%-27.94M | -4,467.62%-12.27M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 28.19%252.92M | -26.26%67.17M | 560.61%84.02M | 25.84%48.25M | -3.04%53.47M | -27.63%197.3M | 19.94%91.08M | -82.01%12.72M | -32.41%38.34M | -20.38%55.15M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -373.24%-948.53M | -923.55%-281.9M | -44.02%83.05M | -14.39%-465.83M | -430.16%-283.86M | 92.41%-200.43M | 92.81%-27.54M | 123.63%148.35M | 55.37%-407.21M | 111.96%85.98M |
Net investment purchase and sale | 107.52%16.03M | -123.46%-13.77M | -49.01%96.95M | 98.00%-8.54M | -293.57%-58.6M | 55.46%-213.26M | -120.48%-6.16M | 470.13%190.14M | -120.77%-427.51M | 108.68%30.28M |
Net proceeds payment for loan | -6,005.16%-963.37M | -1,221.92%-271.85M | 71.91%-11.37M | -2,296.59%-456.34M | -495.49%-223.8M | 100.75%16.31M | 95.00%-20.57M | 93.91%-40.48M | 102.89%20.78M | 115.32%56.59M |
Net PPE purchase and sale | -18.82%-4.65M | 204.99%1.05M | -273.33%-3.58M | -63.98%-1.04M | 18.04%-1.08M | -7.12%-3.91M | 41.52%-1M | -46.56%-960K | -3.09%-633K | -97.30%-1.31M |
Net other investing changes | 715.13%3.45M | 1,302.62%2.68M | 401.13%1.06M | -43.04%90K | -189.93%-384K | -90.28%423K | 170.48%191K | -108.92%-353K | -80.20%158K | 428.46%427K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -373.24%-948.53M | -923.55%-281.9M | -44.02%83.05M | -14.39%-465.83M | -430.16%-283.86M | 92.41%-200.43M | 92.81%-27.54M | 123.63%148.35M | 55.37%-407.21M | 111.96%85.98M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -28.60%941.17M | 34,018.64%831.13M | -65.85%316.39M | -48.81%243.44M | -421.77%-449.8M | 227.18%1.32B | -99.62%2.44M | 244.03%926.35M | 152.90%475.59M | 33.25%-86.21M |
Change in federal funds and securities sold for repurchase | 303.55%737M | 497.22%451.11M | 516.80%445.47M | -36.29%-248.17M | 163.91%88.6M | -289.41%-362.07M | -174.48%-113.57M | -6.39%72.22M | 27.18%-182.09M | -91.12%-138.64M |
Increase decrease in deposit | -84.37%269.95M | 202.69%396.93M | -113.21%-112.86M | -24.51%507.94M | -862.00%-522.06M | 290.58%1.73B | -73.50%131.14M | 218.56%854.16M | 205.73%672.9M | 255.42%68.51M |
Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cash dividends paid | -43.04%-65.47M | -7.38%-16.4M | -58,310.71%-16.36M | -7.34%-16.38M | -7.41%-16.34M | -21.96%-45.77M | -20.95%-15.27M | -134.57%-28K | -21.96%-15.26M | -21.96%-15.21M |
Proceeds from stock option exercised by employees | -28.83%916K | 13.92%311K | --236K | 42.26%239K | -84.63%130K | 4.46%1.29M | 78.43%273K | --0 | -45.63%168K | 52.98%846K |
Net other financing activities | 37.77%-1.23M | -497.81%-819K | ---95K | -49.18%-182K | 92.25%-133K | -72.79%-1.98M | -878.57%-137K | --0 | 62.69%-122K | -179.93%-1.72M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -28.60%941.17M | 34,018.64%831.13M | -65.85%316.39M | -48.81%243.44M | -421.77%-449.8M | 227.18%1.32B | -99.62%2.44M | 244.03%926.35M | 152.90%475.59M | 33.25%-86.21M |
Net cash flow | ||||||||||
Beginning cash position | 161.15%2.13B | -14.76%1.76B | 30.59%1.28B | 66.58%1.45B | 161.15%2.13B | -80.67%816.05M | 322.90%2.07B | -42.10%977.69M | -74.71%870.97M | -80.67%816.05M |
Current changes in cash | -81.33%245.55M | 834.24%616.4M | -55.54%483.47M | -263.17%-174.13M | -1,338.55%-680.19M | 138.61%1.32B | -79.87%65.98M | 190.60%1.09B | 106.08%106.72M | 107.05%54.92M |
End cash position | 11.52%2.38B | 11.52%2.38B | -14.76%1.76B | 30.59%1.28B | 66.58%1.45B | 161.15%2.13B | 161.15%2.13B | 322.90%2.07B | -42.10%977.69M | -74.71%870.97M |
Free cash flow | 28.38%248.27M | -24.27%68.22M | 584.06%80.44M | 25.20%47.21M | -2.67%52.4M | -28.10%193.39M | 21.36%90.08M | -83.21%11.76M | -32.80%37.71M | -21.52%53.84M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |